Search Within

Amanda Rachel Copeland

Formats
  1. Meeting Abstract (19)
  2. Journal Article (6)
Groups
  1. Nursing (25)
  2. Center for Hematologic Malignancies (23)
  3. Department of Medicine (23)
  4. Executive Committee, Center for Hematologic Malignancies (23)
  5. Hematologic Malignancies, Division of (23)
  6. Lymphoma (23)

More Groups

People
  1. Anas Younes (23)
  2. Andrew Zelenetz (13)
  3. Connie Batlevi (12)
  4. John Gerecitano (12)
  5. Craig Moskowitz (11)
  6. Andrew Intlekofer (9)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (5)
  4. 2016 (6)
  5. 2015 (5)
  6. 2014 (4)

More Years

Publications
  1. Blood (10)
  2. Haematologica (3)
  3. Hematological Oncology (2)
  4. Journal of Clinical Oncology (2)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Ferrata Storti Foundation (3)
  3. American Society of Clinical Oncology (2)
  4. Oncology Nursing Society (ONS) (2)
  5. Wiley Blackwell (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Journal Article

    Soumerai, J. D.; Ni, A.; Alperovich, A.; Batlevi, C.; Bantilan, K. S.; Fischer, T.; Copeland, A. R.; Smith, K.; Ying, Z.; Younes, A.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Brentuximab vedotin: A nursing perspective on best practices and management of associated adverse events
    Journal Article

    Clifford, K.; Copeland, A.; Knutzen, G.; Samuelson, E.; Grove, L.; Schiavo, K.
    Clinical Journal of Oncology Nursing (2018)

    Fulltext@MSK | Save
  • Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
    Journal Article

    Intlekofer, A. M.; Joffe, E.; Batlevi, C. L.; Hilden, P.; He, J.; Seshan, V. E.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, C. H.; Portlock, C.; more...
    Blood Cancer Journal (2018)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma
    Journal Article

    Batlevi, C. L.; Crump, M.; Andreadis, C.; Rizzieri, D.; Assouline, S. E.; Fox, S.; van der Jagt, R. H. C.; Copeland, A.; Potvin, D.; Chao, R.; more...
    British Journal of Haematology (2017)

    Fulltext@MSK | Save
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/IB dose escalation and expansion of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C.; Hamlin, P.; Matasar, M.; Gerecitano, J.; Drullinsky, P.; Hamilton, A.; Straus, D.; Horwitz, S.; Kumar, A.; Moskowitz, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Treatment-related adverse events with nivolumab in patients with relapsed/refractory classical Hodgkin lymphoma: Results from a cohort analysis of the phase 2 CheckMate 205 study
    Meeting Abstract

    Wesson, E.; Klebig, R.; Stephans, K.; Palmer, A.; Kurosky, A.; Copeland, A.
    Oncology Nursing Forum (2017)

    Fulltext@MSK | Save
  • The final report of a phase I/II study of panobinostat in combination with ICE (ifosfamide, carboplatin and etoposide) in patients (pts) with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL)
    Meeting Abstract

    Hu, B.; Younes, A.; Claret, L.; Feng, L.; Westin, J. R.; Fowler, N.; Neelapu, S.; Hagemeister, F. B.; Rodriguez, M. A.; Samaniego, F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save